(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1,028.83%1.51M | -62.50%501K | 2.32%1.15M | 598.68%758K | -230.04%-1.21M | 71.25%-163K | -85.67%1.34M | -34.02%1.12M | -105.07%-152K | -58.19%932K |
Net income from continuing operations | -39.15%-3.55M | -13.95%-13.19M | -48.00%-3.56M | -5.97%-3.09M | -28.12%-3.99M | 18.82%-2.55M | 23.73%-11.57M | 73.13%-2.41M | -29.18%-2.91M | -73.27%-3.11M |
Operating gains losses | -36.84%24K | -64.57%90K | -44.58%46K | --16K | --20K | -77.78%38K | -10.88%254K | -28.45%83K | ---- | ---- |
Depreciation and amortization | -4.92%2.36M | -1.10%9.97M | -2.17%2.47M | -0.43%2.55M | -1.28%2.47M | -0.52%2.48M | -30.71%10.09M | -31.37%2.53M | -29.63%2.56M | -30.90%2.5M |
Asset impairment expenditure | -20.00%48K | -29.79%297K | 811.11%64K | 62.07%94K | -68.90%79K | -50.00%60K | -93.64%423K | -100.14%-9K | -28.40%58K | 262.86%254K |
Remuneration paid in stock | -9.41%183K | -14.24%590K | 97.39%227K | -15.72%193K | -118.71%-32K | 16.76%202K | 319.51%688K | 124.47%115K | 47.74%229K | -31.60%171K |
Other non cashItems | 155.15%1.46M | 3.42%3.69M | -33.89%915K | 91.27%811K | 13.32%1.39M | 7.71%573K | -15.61%3.56M | -33.04%1.38M | -46.40%424K | 69.06%1.22M |
Change In working capital | 202.17%987K | 54.86%-951K | 271.73%984K | 135.16%180K | -973.83%-1.15M | -5.57%-966K | -52.24%-2.11M | -110.66%-573K | -500.00%-512K | 85.87%-107K |
-Change in receivables | 626.32%300K | 55.56%-16K | -79.95%174K | 82.69%-153K | -89.42%20K | 72.73%-57K | 78.31%-36K | 1,140.00%868K | -410.98%-884K | 420.34%189K |
-Change in prepaid assets | -39.60%-282K | 118.60%149K | 138.65%160K | 335.16%301K | -164.71%-110K | 52.91%-202K | -2,862.07%-801K | -800.00%-414K | -168.09%-128K | 176.58%170K |
-Change in payables and accrued expense | 247.68%923K | 0.17%-1.14M | 159.87%634K | -99.09%5K | -172.24%-1.16M | -196.21%-625K | -9.26%-1.15M | -274.20%-1.06M | 2,600.00%550K | -8.70%-425K |
-Change in other working capital | 156.10%46K | 147.20%59K | -50.00%16K | 154.00%27K | 339.02%98K | -24.24%-82K | 37.19%-125K | 346.15%32K | -137.04%-50K | 51.76%-41K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 1,028.83%1.51M | -62.50%501K | 2.32%1.15M | 598.68%758K | -230.04%-1.21M | 71.25%-163K | -85.67%1.34M | -55.35%1.12M | -105.88%-152K | -58.19%932K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 50.89%-1.26M | -126.67%-5.02M | 18.33%-1.39M | 31.61%-608K | 83.72%-455K | -110.63%-2.57M | 342.81%18.83M | -21.21%-1.7M | 52.96%-889K | -22.92%-2.79M |
Net PPE purchase and sale | 40.03%-1.11M | 13.78%-5.36M | 30.10%-1.07M | -4.81%-980K | 23.84%-1.46M | -0.93%-1.85M | 15.83%-6.21M | -13.87%-1.54M | 37.29%-935K | 14.90%-1.91M |
Net intangibles purchas and sale | 14.63%-140K | ---593K | ---150K | ---149K | ---130K | ---164K | --0 | --0 | --0 | --0 |
Net investment purchase and sale | ---- | 178.58%910K | --0 | --0 | 30,433.33%910K | ---- | ---1.16M | ---19K | --0 | ---3K |
Net other investing changes | 97.15%-16K | -99.93%18K | -13.99%-163K | 1,032.61%521K | 125.28%222K | -102.07%-562K | 7,122.79%26.2M | -175.00%-143K | 111.53%46K | -3,412.00%-878K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 50.89%-1.26M | -126.67%-5.02M | 18.33%-1.39M | 31.61%-608K | 83.72%-455K | -110.63%-2.57M | 342.81%18.83M | -21.21%-1.7M | 52.96%-889K | -22.92%-2.79M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -28.43%-2.16M | 113.90%2.69M | -66.35%1.72M | -52.61%-2.08M | 411.26%4.73M | 92.22%-1.68M | -893.78%-19.34M | 319.66%5.1M | 64.84%-1.36M | -121.59%-1.52M |
Net issuance payments of debt | -28.43%-2.16M | 121.62%4.25M | -58.25%1.99M | -12.34%-1.53M | 439.57%5.16M | 92.22%-1.68M | -20.61%-19.66M | 289.37%4.78M | 64.70%-1.36M | 79.09%-1.52M |
Cash dividends paid | ---- | --0 | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | 53.18%337K | ---- | ---- | ---- | ---- | -70.39%220K | ---- | ---- | ---- |
Interest paid (cash flow from financing activities) | ---- | -544.07%-1.9M | -108.81%-616K | ---548K | ---430K | ---- | 71.30%-295K | ---295K | --0 | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | -52.24%395K | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -28.43%-2.16M | 113.90%2.69M | -66.35%1.72M | -52.61%-2.08M | 411.26%4.73M | 92.22%-1.68M | -893.78%-19.34M | 319.66%5.1M | 64.84%-1.36M | -121.59%-1.52M |
Net cash flow | ||||||||||
Beginning cash position | -29.57%4.38M | 13.48%6.22M | 63.39%2.91M | 15.63%4.84M | -76.51%1.78M | 13.48%6.22M | -6.44%5.48M | -73.36%1.78M | -57.58%4.18M | 163.74%7.56M |
Current changes in cash | 56.85%-1.9M | -322.87%-1.83M | -67.32%1.48M | 19.78%-1.93M | 190.54%3.06M | -311.86%-4.41M | 318.04%822K | 475.27%4.52M | 24.32%-2.4M | -148.36%-3.38M |
Effect of exchange rate changes | 66.67%-10K | 91.57%-7K | ---- | ---- | ---- | ---30K | ---83K | ---- | ---- | ---- |
End cash Position | 38.83%2.47M | -29.57%4.38M | -29.57%4.38M | 63.39%2.91M | 15.66%4.84M | -76.51%1.78M | 13.48%6.22M | 13.48%6.22M | -73.36%1.78M | -57.58%4.18M |
Free cash from | 112.29%267K | -11.73%-5.45M | 82.04%-74K | 65.87%-371K | -185.32%-2.8M | 9.31%-2.17M | -351.08%-4.88M | -135.30%-412K | -199.18%-1.09M | -5,063.16%-981K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.